Poor immune response to hepatitis B vaccination in hemodialysis patients
dc.contributor.author | Yazanel O. | |
dc.contributor.author | Canoruc F. | |
dc.contributor.author | Isikoglu B. | |
dc.date.accessioned | 2024-04-24T17:58:55Z | |
dc.date.available | 2024-04-24T17:58:55Z | |
dc.date.issued | 1996 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | For active immunization against infection caused by hepatitis B virus, 25 hemodialysis patients (13 men, 12 women, 15-62 years old range) were vaccinated with the close of 20-40 microgram recombinant DNA vaccine, three times one month apart. At the first evaluation 2 months after the last vaccination, we were able to include in the study 24 hemodialysis patients and 27 healthy relatives. Of 24 hemodialysis patients, 14 (58.3%) and of 27 healthy relatives, 25 (93%) developed anti-HBs antibody. Six months after the last vaccination (second evaluation), two men more had anti-HBs antibody. Thus, totally 16 hemodialysis patients responded to hepatitis B vaccination (66.6%). Immune reactivity seems to correlate with the uremic (p<0.05) and nutritional status. Women were more likely (75%) to be responder than men (50%), and the younger patients (<40 years old) correlated significantly with the antibody response. In conclusion, since these patients had a poor antibody response to standard vaccination, alternative hepatitis B vaccination regimens may have to be planned in this particular group of patients. | en_US |
dc.identifier.endpage | 135 | en_US |
dc.identifier.issn | 1300-4948 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.scopus | 2-s2.0-0029950161 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 131 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/24155 | |
dc.identifier.volume | 7 | en_US |
dc.indekslendigikaynak | Scopus | |
dc.language.iso | tr | en_US |
dc.relation.ispartof | Turkish Journal of Gastroenterology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Anti-Hbs Antibody | en_US |
dc.subject | Chronic Hemodialysis Patients | en_US |
dc.subject | Hepatitis B (Hb) Vaccination | en_US |
dc.title | Poor immune response to hepatitis B vaccination in hemodialysis patients | en_US |
dc.title.alternative | HEMODIALIZ HASTALARINDA HEPATITIS B ASILAMASINA ZAYIF IMMUN YANIT | en_US |
dc.type | Article | en_US |